China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)
CUSIP: G2161P140
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common stock, $0.08 par value
- Total 13F shares
- 10,008
- Share change
- -36,507
- Total reported value
- $5,085
- Price per share
- $0.50
- Number of holders
- 2
- Value change
- -$21,536
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP G2161P140?
CUSIP G2161P140 identifies SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G2161P140:
Top shareholders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
—
class O/S missing
|
12,300
|
$9,000 | — | 30 Sep 2024 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
—
class O/S missing
|
15,161
|
$7,927 | — | 30 Sep 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
—
class O/S missing
|
10,000
|
$6,420 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
8,678
|
$6,335 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
class O/S missing
|
376
|
$274 | — | 30 Sep 2024 | |
| Feng Felix Zhou |
3/4/5
|
Co-CEO and Director, Director |
—
class O/S missing
|
4
|
— | — | 04 Jul 2017 |
Institutional Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.